237 related articles for article (PubMed ID: 22976575)
1. Management of gastric carcinoids (neuroendocrine neoplasms).
Kidd M; Gustafsson BI
Curr Gastroenterol Rep; 2012 Dec; 14(6):467-72. PubMed ID: 22976575
[TBL] [Abstract][Full Text] [Related]
2. Gastric Carcinoids.
Grozinsky-Glasberg S; Alexandraki KI; Angelousi A; Chatzellis E; Sougioultzis S; Kaltsas G
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):645-660. PubMed ID: 30098721
[TBL] [Abstract][Full Text] [Related]
3. Gastric carcinoids (neuroendocrine neoplasms).
Kidd M; Gustafsson B; Modlin IM
Gastroenterol Clin North Am; 2013 Jun; 42(2):381-97. PubMed ID: 23639647
[TBL] [Abstract][Full Text] [Related]
4. A clinical perspective on gastric neuroendocrine neoplasia.
Lawrence B; Kidd M; Svejda B; Modlin I
Curr Gastroenterol Rep; 2011 Feb; 13(1):101-9. PubMed ID: 21080245
[TBL] [Abstract][Full Text] [Related]
5. Hypergastrinemia and recurrent type 1 gastric carcinoid in a young Indian male: necessity for antrectomy?
Senadhi V; Jani N
World J Gastroenterol; 2011 Sep; 17(35):4052-4. PubMed ID: 22046097
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
[TBL] [Abstract][Full Text] [Related]
7. Management of carcinoid tumors of the stomach, duodenum, and pancreas.
Akerström G
World J Surg; 1996 Feb; 20(2):173-82. PubMed ID: 8661814
[TBL] [Abstract][Full Text] [Related]
8. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia.
Hoshino M; Omura N; Yano F; Tsuboi K; Matsumoto A; Yamamoto SR; Akimoto S; Kashiwagi H; Yanaga K
Hepatogastroenterology; 2010; 57(98):379-82. PubMed ID: 20583448
[TBL] [Abstract][Full Text] [Related]
10. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.
Borch K; Ahrén B; Ahlman H; Falkmer S; Granérus G; Grimelius L
Ann Surg; 2005 Jul; 242(1):64-73. PubMed ID: 15973103
[TBL] [Abstract][Full Text] [Related]
11. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
[TBL] [Abstract][Full Text] [Related]
12. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
13. Deletion of
Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
[TBL] [Abstract][Full Text] [Related]
14. Review article: the investigation and management of gastric neuroendocrine tumours.
Basuroy R; Srirajaskanthan R; Prachalias A; Quaglia A; Ramage JK
Aliment Pharmacol Ther; 2014 May; 39(10):1071-84. PubMed ID: 24628514
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Berretti D; Castellani D; Cacciari G; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2016 Jan; 51(1):131-9. PubMed ID: 25814125
[TBL] [Abstract][Full Text] [Related]
16. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
Bordi C; Falchetti A; Azzoni C; D'Adda T; Canavese G; Guariglia A; Santini D; Tomassetti P; Brandi ML
Am J Surg Pathol; 1997 Sep; 21(9):1075-82. PubMed ID: 9298884
[TBL] [Abstract][Full Text] [Related]
17. Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis.
Rossi RE; Invernizzi P; Mazzaferro V; Massironi S
United European Gastroenterol J; 2020 Mar; 8(2):140-147. PubMed ID: 32213066
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine neoplasms of the stomach.
Louthan O
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):455-60. PubMed ID: 23817299
[TBL] [Abstract][Full Text] [Related]
19. Gastric carcinoids: Does type of surgery or tumor affect survival?
Crown A; Kennecke H; Kozarek R; Lopez-Aguiar AG; Dillhoff M; Beal EW; Poultsides GA; Makris E; Idrees K; Smith PM; Nathan H; Beems M; Abbott D; Fisher AV; Fields RC; Davidson J; Maithel SK; Rocha FG
Am J Surg; 2019 May; 217(5):937-942. PubMed ID: 30686481
[TBL] [Abstract][Full Text] [Related]
20. Gastric Neuroendocrine Tumors (Carcinoids).
Gluckman CR; Metz DC
Curr Gastroenterol Rep; 2019 Mar; 21(4):13. PubMed ID: 30868284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
